SEC Form 4 · accession 0001181431-15-008327
STERIS CORP · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Allen Johnson
Officer — Sr. VP. Surgical Solutions
Period of report
Jun 15, 2015
Accepted (ET)
Jun 15, 2015 · 6:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815065
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par ValueF1,F2,F3 | Jun 15, 2015 | S | 1,826 | $63.0755 | D | 27,037 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involved the open market sale on June 15, 2015 of a total of 1,826 shares, held by the Reporting Person, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 5, 2014.
- F2This represents the average sales price of the 1,826 shares sold in the open market. The actual 14 sales prices ranged from $62.2300 per share to $63.3100 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 14 sales prices.
- F315,500 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 3,500 on May 31, 2016; 7,000 May 31, 2017; 3,750 on May 30, 2017 and 1,250 on May 30, 2018.